UBS cuts Abercrombie & Fitch target to $210, maintains buy

Published 24/02/2025, 22:54
Updated 24/02/2025, 22:56
UBS cuts Abercrombie & Fitch target to $210, maintains buy

On Monday, UBS analyst Mauricio Serna revised the price target for Abercrombie & Fitch (NYSE:ANF) stock, decreasing it to $210 from the previous $220, while continuing to endorse the stock with a Buy rating. The adjustment in the price target reflects a modest reduction in the anticipated earnings per share (EPS) for the fiscal year 2026, as well as additional marketing investments projected to support growth in subsequent years.

Serna explained that the new price target is based on approximately 16 times the revised $13.05 earnings per share estimate for fiscal year 2026. The company currently trades at a P/E ratio of 9.75, with impressive gross profit margins of 64.66%. The decrease in the price target is attributed to a lower revenue base forecast for fiscal year 2025 and the aforementioned increase in marketing expenditures. Additionally, slight alterations in the price-to-earnings (P/E) ratio used in the valuation model contributed to the change in the target price.

The analyst emphasized that, despite some inconsistent data in the near term, the fundamentals of Abercrombie & Fitch are strong, and the expectation is that the stock will perform better than the market over the next twelve months (NTM). According to UBS, the new price target of $210 aligns Abercrombie & Fitch’s valuation with that of its industry peers when considering metrics such as P/E, price-to-sales (P/Sales), and enterprise value to earnings before interest, taxes, depreciation, and amortization (EV/EBITDA).

Serna’s commentary reinforces UBS’s confidence in Abercrombie & Fitch’s core business strengths and its potential for stock performance in the near term. Despite the reduction in the price target, the firm’s outlook on the stock remains positive, as indicated by the maintained Buy rating.

In other recent news, Abercrombie & Fitch Co. announced an upward revision of its net sales forecast for both the fourth quarter and the entire fiscal year of 2024. The company now anticipates fourth-quarter sales growth between 7% and 8%, and full-year growth around 15%. CEO Fran Horowitz attributed this positive adjustment to strong comparable sales across regions and brands during the holiday season. Despite this optimistic sales outlook, the company maintained its operating margin expectations for both periods.

Separately, UBS reaffirmed its Buy rating on Abercrombie & Fitch, maintaining a price target of $220. The firm highlighted the company’s appealing valuation and strong brand fundamentals within the Specialty Retail sector. UBS anticipates that earnings per share growth will be a key driver for the stock’s future performance. Additionally, JPMorgan increased its price target for Abercrombie & Fitch to $204, citing strong momentum and successful operating strategies.

William Blair, however, maintained a Market Perform rating, expressing caution about the company’s ability to sustain its operating margin amid expansion efforts. The firm noted potential challenges if the Abercrombie brand underperforms, especially at the retail level. These recent developments indicate varied analyst perspectives, reflecting both optimism and caution about Abercrombie & Fitch’s future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.